Shanghai, China, May 11th, 2023 -- Zencore Biologics has signed a strategic cooperation agreement with NNIT, a well-known digital solutions provider based in Denmark. Under the agreement, NNIT will help Zencore Biologics create a more reliable digital platform by developing end-to-end digital solutions for the pharmaceutical lifecycle, enabling efficient operations in technology and management, and providing high-quality drug R&D and commercial production services to domestic and international clients.
Mr. Jianxin Chen ,Chairman and CEO of Zencore Biologics (left)
Mr. Pär Fors, CEO of NNIT (right)
